News for Healthier Living

In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the disease. The New England Journal of Medicine published the innovative clinical trial results this week.

October 16, 2024


October 19 2024

October 18 2024

October 17 2024

October 16 2024

October 15 2024

October 14 2024

October 13 2024

October 12 2024

October 11 2024

October 10 2024

October 9 2024

October 8 2024

October 7 2024

October 6 2024

October 5 2024